CCB
NVS icon

Cutter & Co Brokerage’s Novartis NVS Stock Holding History

Cutter & Co Brokerage’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,124
Closed -$940K – 234
2022
Q2 		$940K Sell
11,124
-305
-3% -$26.8K 0.32% 73
2022
Q1 		$1M Sell
11,429
-265
-2% -$22.9K 0.3% 73
2021
Q4 		$1.02M Buy
11,694
+2,090
+22% +$174K 0.28% 84
2021
Q3 		$785K Buy
9,604
+775
+9% +$69.7K 0.19% 112
2021
Q2 		$806K Buy
8,829
+35
+0.4% +$3.12K 0.19% 111
2021
Q1 		$752K Buy
8,794
+53
+0.6% +$4.76K 0.18% 112
2020
Q4 		$825K Sell
8,741
-365
-4% -$31.9K 0.22% 98
2020
Q3 		$792K Sell
9,106
-720
-7% -$62.4K 0.23% 93
2020
Q2 		$858K Sell
9,826
-149
-1% -$12.9K 0.28% 86
2020
Q1 		$822K Sell
9,975
-422
-4% -$37.7K 0.31% 79
2019
Q4 		$985K Hold
10,397
– – 0.35% 76
2019
Q3 		$904K Sell
10,397
-400
-4% -$35.9K 0.29% 85
2019
Q2 		$986K Sell
10,797
-2,799
-21% -$237K 0.31% 80
2019
Q1 		$1.17M Sell
13,596
-72
-0.5% -$5.78K 0.33% 70
2018
Q4 		$1.05M Buy
13,668
+236
+2% +$18.4K 0.4% 69
2018
Q3 		$1.04M Buy
13,432
+577
+4% +$42.7K 0.35% 75
2018
Q2 		$870K Sell
12,855
-137
-1% -$9.45K 0.34% 81
2018
Q1 		$941K Sell
12,992
-62
-0.5% -$4.72K 0.37% 72
2017
Q4 		$982K Buy
13,054
+614
+5% +$46.3K 0.4% 65
2017
Q3 		$957K Sell
12,440
-446
-3% -$33.7K 0.38% 70
2017
Q2 		$964K Sell
12,886
-295
-2% -$20.9K 0.38% 67
2017
Q1 		$877K Sell
13,181
-374
-3% -$24.9K 0.36% 69
2016
Q4 		$885K Buy
13,555
+698
+5% +$45.3K 0.37% 69
2016
Q3 		$910K Sell
12,857
-254
-2% -$18.5K 0.4% 67
2016
Q2 		$969K Buy
13,111
+527
+4% +$36.4K 0.41% 65
2016
Q1 		$817K Buy
+12,584
New +$856K 0.38% 71

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Cutter & Co Brokerage's NVS Position: Q3 2022 in Review

Cutter & Co Brokerage sold out of Novartis (NVS) in Q3 2022, closing a stake of 11,124 shares — an estimated $940K sold.

Cutter & Co Brokerage first reported a position in NVS in Q1 2016 and held it in 26 quarters. The position peaked at $1.17M in Q1 2019. 1,088 funds tracked by Wall St. Rank hold NVS as of Q3 2022.

  • Cutter & Co Brokerage reported no remaining Novartis position as of Q3 2022 after selling out during the quarter.
  • Cutter & Co Brokerage sold 11,124 Novartis shares in Q3 2022, an estimated $940K.
  • Cutter & Co Brokerage first reported a position in Novartis in Q1 2016 and held it in 26 quarters.
  • Cutter & Co Brokerage's Novartis position peaked at $1.17M in Q1 2019.
  • 1,088 funds tracked by Wall St. Rank held Novartis as of Q3 2022.

Based on Cutter & Co Brokerage's 13F filing for Q3 2022, filed 3 Nov 2022.